Alarm over loss of life in clinical trial for arthritis therapy The death of a female taking part in a clinical trial for an arthritis therapy has set alarm bells ringing in the usa. The 36 year previous Illinois woman died on July 24th from internal bleeding and organ failing after receiving the next injection of an experimental gene therapy treatment to treat her rheumatoid arthritis. Jolee Mohr, who includes a 5-year-old daughter, took component in the study because she believed it could help the arthritis rheumatoid which affected her whole body. Her death provides triggered a U.S. Government investigation and resulted in the suspension of the gene therapy research being executed by the Seattle firm Targeted Genetics. Related StoriesNovel modular partial wrist implant may provide relief for sufferers with painful wrist arthritisNo progression in joint damage in 84 percent of psoriatic arthritis patientsArthritis increases risk of falling into poverty, brand-new research showsThe research involved a hundred patients and other such research around the country are also right now under review.Siriwardena noted that it remains to be to be seen whether the advantage of the flu vaccine may be lesser or greater, based on a patient’s particular risk profile for stroke. Dr. Gregg Fonarow, a professor of cardiology at the University of California, LA, said that while those at higher risk for stroke may derive the best benefit with regards to stroke risk decrease, given the devastating impact that strokes can possess, also modest reductions in stroke risk [are] worthwhile. Based on the fit, many hospitals have confronted rulings by the auditors that care provided and billed on an inpatient basis should have been performed in an outpatient setting. Hospitals are forced to come back the money paid for the services then.